Global Antibacterial Drugs Market to 2022
Report Description
Summary
•
The antibacterial drug market covers the drugs used in the prophylaxis and treatment of bacterial infections.
•
With a growing global concern over antimicrobial resistance and its progressive growth, there is a pronounced need for innovation within this market.
•
This report considers the key developments in this market, with particular focus on drugs indicated for use in pneumonia, methicillin-resistant staphylococcus aureus (MRSA), sepsis and tuberculosis.
•
Drugs for the prevention of bacterial infections are typically vaccines, which help to train the body’s immune system to fight off specific infections, and can therefore help to prevent infections of certain bacterial strains.
•
However, several prophylactic monoclonal antibodies are also currently in development.
Continued…
Scope •
How big is the antibiotic pipeline?
•
How are companies attempting to overcome antibiotic resistance? The antibacterial drug market is forecast to rise from around $27.1 billion in 2015 to $35.6 billion in 2022:
•
How much will the approval of new products and the patent expiries of existing ones contribute to this market growth?
•
Will vaccines continue to drive market revenue?
Download a Sample @
https://www.24marketreports.com/request-sample/global-an tibacterial-drugs-market-to-2022---vaccines-retain-marke t-prominence-while-pipeline-offers-innovative-approaches
Table of content 1 Table of Contents 4 1.1 List of Tables 6 1.2 List of Figures 7 2 Introduction 10 2.1 Disease Cluster Introduction 10 2.2 Symptoms 11 2.3 Diagnosis 12 2.4 Etiology and Pathophysiology 13 3 Key Marketed Products 24 3.1 Overview 24 3.2 Cubicin (daptomycin) – Merck & Co 25
Visit us at : https://www.24marketreports.com/life-sciences/globa l-antibacterial-drugs-market-to-2022---vaccines-ret ain-market-prominence-while-pipeline-offers-innovat ive-approaches-to-tackling-antimicrobial-resistance Stay With Us:
TELEPHONE: (+1) 646 781 7170 Email: help@24marketreports.com
New York City Zone 01, United States,.